Benzylpiperazine urea TRPV1 antagonistic and MOR agonistic double-target drug as well as preparation method and application thereof

The invention belongs to the technical field of pharmacy, particularly discloses a benzylpiperazine urea TRPV1 antagonistic and MOR agonistic double-target drug as well as a preparation method and application thereof, and particularly relates to a compound in a general formula (I) and pharmaceutical...

Full description

Saved in:
Bibliographic Details
Main Authors GAO MENGKANG, CHEN YINGDA, SONG DEPU, QIAO ZHENRUI, WANG GUOHAO, YAN LIN, WANG YUSUI
Format Patent
LanguageChinese
English
Published 24.08.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention belongs to the technical field of pharmacy, particularly discloses a benzylpiperazine urea TRPV1 antagonistic and MOR agonistic double-target drug as well as a preparation method and application thereof, and particularly relates to a compound in a general formula (I) and pharmaceutically acceptable salts thereof, and the drug can be used for preventing and/or treating diseases related to TRPV1 and/or MOR activity, such as pain, inflammation, immune dysfunction, neurological and psychiatric disorders, respiratory diseases, urinary and reproductive disorders. the invention also relates to a preparation method of the compounds and a pharmaceutical preparation containing the compounds. 本发明属于制药技术领域,具体公开了一种苄基哌嗪脲类TRPV1拮抗和MOR激动双靶点药物及其制备方法和应用,尤其涉及通式(Ⅰ)中化合物及其药学上可接受的盐,该药物可以用于预防和/或治疗与TRPV1和/或MOR活性相关的疾病,如疼痛、炎症、免疫功能障碍、神经和精神病症、呼吸道疾病、泌尿和生殖病症;本发明还涉及该类化合物的制备方法及含有它们的药物制剂;
Bibliography:Application Number: CN202110639985